Regenerative Medicine of the Larynx. Where are we Today? A Review

被引:19
|
作者
Gugatschka, Markus [1 ]
Ohno, Satoshi [2 ]
Saxena, Amulya [3 ]
Hirano, Shigeru [2 ]
机构
[1] Med Univ Graz, ENT Univ Hosp Graz, Dept Phoniatr, A-8036 Graz, Austria
[2] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan
[3] Med Univ Graz, Dept Pediat & Adolescent Surg, Unit Expt Fetal Surg & Tissue Engn, Graz, Austria
关键词
Regenerative medicine; Larynx; Tissue engineering; HEPATOCYTE GROWTH-FACTOR; VOCAL FOLD FIBROBLASTS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX PRODUCTION; BOVINE ACELLULAR SCAFFOLD; SIDE POPULATION CELLS; LAMINA PROPRIA; IN-VIVO; ATELOCOLLAGEN SHEET; TISSUE REGENERATION;
D O I
10.1016/j.jvoice.2012.03.009
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Tissue engineering is a multidimensional process combining cells, scaffold matrices, and chemical signals to produce a structure similar to a target tissue. These techniques have opened a completely new field in diagnosis and therapy in numerous fields, including that of laryngology. Laryngeal tissue engineering has emerged in the last decade, although clinical applications are rare. The reasons therefore are numerous including ethical reasons, as well as the extremely complex anatomical structure of the vocal fold. The search for new treatment options has also enlarged our knowledge about the microphysiology and micropathophysiology of the vocal fold. To date, only specific growth factors are in clinical use for treatment of vocal fold atrophy. Big advances have been made in creating state-of-the-art scaffolds with various techniques including biomaterials as well as fully synthetic polymers. These scaffolds are supposed to provide an optimal environment for residual or implanted cells. Several in vitro settings showed practicability of these scaffolds, also in studying effects of growth factors. Cell therapy is a powerful tool in regenerative medicine but bears the uncertainty of possible malignant transformation. The aim of this review was to give a comprehensive overview about current knowledge in the field of laryngeal tissue engineering and regenerative medicine, including restoration of both vocal folds and laryngeal cartilage, and furthermore to elucidate further trends in this fascinating field.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Bioengineered larynx and vocal folds: where are we today? A review
    Kaboodkhani, Reza
    Moghaddam, Armaghan
    Mehrabani, Davood
    Khonakdar, Hossein Ali
    BIOMEDICAL MATERIALS, 2024, 19 (06)
  • [2] Regenerative medicine: where are we at?
    Thomas, R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A165 - A165
  • [3] Regenerative Medicine in Urogynecology: Where We Are and Where We Want to Be
    Henderson, Tatyanna
    Christman, Karen L.
    Alperin, Marianna
    UROGYNECOLOGY, 2024, 30 (05): : 519 - 527
  • [4] Regenerative Medicine in Urogynecology: Where We Are and Where We Want to Be
    Henderson, Tatyanna
    Christman, Karen L.
    Alperin, Marianna
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2024, 79 (09) : 517 - 519
  • [5] Where Are We Today with Personalized Medicine?
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2012, 50 (11) : 11 - 13
  • [6] Personalized medicine in cancer: where are we today?
    Turnbull, Arran K.
    FUTURE ONCOLOGY, 2015, 11 (20) : 2795 - 2798
  • [7] Pain medicine - where we stand today
    Schafer, M.
    SCHMERZ, 2015, 29 (05): : 464 - 464
  • [8] Regenerative medicine in kidney disease: where we stand and where to go
    Borges, Fernanda T.
    Schor, Nestor
    PEDIATRIC NEPHROLOGY, 2018, 33 (09) : 1457 - 1465
  • [9] Regenerative medicine in kidney disease: where we stand and where to go
    Fernanda T. Borges
    Nestor Schor
    Pediatric Nephrology, 2018, 33 : 1457 - 1465
  • [10] Myofibroblastic sarcoma of the larynx. A case report and review
    Schroeder, S.
    Stengel, B.
    Radtke, A.
    Kleemann, D.
    HNO, 2009, 57 (12) : 1311 - 1316